Molsidomine: Difference between revisions
m (Protected "Molsidomine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 4: | Line 4: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 23: | Line 23: | ||
[[fr:Molsidomine]] | [[fr:Molsidomine]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 17:30, 9 August 2012
|
WikiDoc Resources for Molsidomine |
|
Articles |
|---|
|
Most recent articles on Molsidomine Most cited articles on Molsidomine |
|
Media |
|
Powerpoint slides on Molsidomine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Molsidomine at Clinical Trials.gov Clinical Trials on Molsidomine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Molsidomine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Molsidomine Discussion groups on Molsidomine Patient Handouts on Molsidomine Directions to Hospitals Treating Molsidomine Risk calculators and risk factors for Molsidomine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Molsidomine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Molsidomine is an orally active, long acting vasodilating drug. Molsidomine is metabolized in the liver to the active metabolite SIN-1. SIN-1 is an unstable compound that releases nitric oxide upon decay as the actual vasodilating compound.
Chemistry
Molsidomine as well as SIN-1 are sydnone imines, a class of mesoionic heterocyclic aromatic chemical compounds.
See also
- Nitric oxide
- Nitric oxide releaser
- Vasodilator